⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2494175 | 0.81 | — | — | |
| SCHEMBL4281995 | 0.78 | — | — | |
| SCHEMBL9301971 | 0.76 | — | — | |
| SCHEMBL9301976 | 0.76 | — | — | |
| SCHEMBL6373292 | 0.76 | SPHK2 (0.41) | — | |
| SCHEMBL9252230 | 0.74 | SPHK2 (0.45) | — | |
| Hydrochloric Acid SCHEMBL28273045 | 0.73 | SPHK1 (0.43) | — | |
| SCHEMBL5408417 | 0.73 | — | — | |
| SCHEMBL28401677 | 0.72 | MEN1 (0.34) | — | |
| SCHEMBL5665035 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 906 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218022-A1 | ANTI-VISTA MACROCYCLIC PEPTIDES AND COMPOSITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-07-04 | — | — | US | claimed |
| CN-118076741-A | Modified mRNA, modified non-coding RNA and uses thereof | 布罗德研究所股份有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-118055943-A | Cyclic peptide antibiotics | 基因泰克公司 | 2024-05-17 | — | — | CN | claimed |
| WO-2024096066-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING CENTRAL NERVOUS SYSTEM INJURY/DISEASE | 第一工業製薬株式会社 | 2024-05-10 | — | — | WO | claimed |
| WO-2024096067-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING NEUROPATHIC PAIN AND/OR INFLAMMATORY PAIN | 第一工業製薬株式会社 | 2024-05-10 | — | — | WO | claimed |
| US-20240116988-A1 | ANTI-ROR1 MACROCYCLIC PEPTIDES AND COMPOSITIONS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-04-11 | — | — | US | claimed |
| EP-4347618-A1 | CYCLIC PEPTIDE ANTIBIOTICS | Genentech, Inc. (US) | 2024-04-10 | — | — | EP | claimed |
| WO-2024071370-A1 | CYCLIC PEPTIDE DERIVATIVE COMPOSITION FOR TREATING OR PREVENTING EYE DISEASE | 第一工業製薬株式会社 | 2024-04-04 | — | — | WO | claimed |
| WO-2024059472-A1 | MACROCYCLIC IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2024-03-21 | — | — | WO | claimed |
| CN-114276411-B | Solid phase synthesis method of cyclic peptide compound containing trithioether bond | 北京大学深圳研究生院 | 2024-02-09 | — | — | CN | claimed |
| US-4228184-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1980-10-14 | — | — | US | claimed |
| US-4207336-A | AGIOTENSIN RELATED HYPERTENSION | E. R. SQUIBB & SONS, INC. (US) | 1980-06-10 | — | — | US | claimed |
| US-4207342-A | Relieving hypertension with carboxyalkylacylamino acids | E. R. SQUIBB & SONS, INC. (US) | 1980-06-10 | — | — | US | claimed |
| US-4172148-A | GLYCINE, LEUCINE, ISOLEUCINE, VALINE, THREONINE, LYSINE, METHIONINE, ARGININE | E. R. SQUIBB & SONS, INC. (US) | 1979-10-23 | — | — | US | claimed |
| US-4156786-A | Amino acid derivatives | E. R. SQUIBB & SONS, INC. (US) | 1979-05-29 | — | — | US | claimed |
| US-4153725-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-05-08 | — | — | US | claimed |
| US-4146641-A | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1979-03-27 | — | — | US | claimed |
| US-4146611-A | HYPOTENSIVE AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1979-03-27 | — | — | US | claimed |
| US-4105789-A | Carboxyalkylacylamino acids | E. R. SQUIBB & SONS, INC. (US) | 1978-08-08 | — | — | US | claimed |
| US-4053651-A | MERCAPTOACYL AMINO ACIDS, ENZYME INHIBITORS | E. R. SQUIBB & SONS, INC. (US) | 1977-10-11 | — | — | US | claimed |